Journal of the American College of Radiology最新文献_第5页

Hepatocellular Carcinoma Screening: From Current Standard of Care to Future Directions

IF 4 3区医学

Journal of the American College of Radiology Pub Date : 2025-03-01 DOI: 10.1016/j.jacr.2024.10.014

Michael Mohnasky MBS , Sandra Gad MSc , Andrew Moon MD, MPH , A. Sidney Barritt MD, MSCR , Resmi A. Charalel MD, MPH , Caroline Eckblad , Andrew Caddell , Minzhi Xing MD, MPH , Nima Kokabi MD

{"title":"Hepatocellular Carcinoma Screening: From Current Standard of Care to Future Directions","authors":"Michael Mohnasky MBS , Sandra Gad MSc , Andrew Moon MD, MPH , A. Sidney Barritt MD, MSCR , Resmi A. Charalel MD, MPH , Caroline Eckblad , Andrew Caddell , Minzhi Xing MD, MPH , Nima Kokabi MD","doi":"10.1016/j.jacr.2024.10.014","DOIUrl":"10.1016/j.jacr.2024.10.014","url":null,"abstract":"<div><div>Hepatocellular carcinoma (HCC) represents a significant portion of global cancer incidence and mortality. Screening with ultrasound with or without alpha-fetoprotein is recommended for those at high-risk. Although screening can lead to earlier treatment and better outcomes, existing screening paradigms have several flaws. Ultrasound does not capture all early lesions and has lower efficacy in specific populations such as patients with obesity or those with metabolic dysfunction-associated steatotic liver disease (MASLD). Additionally, individuals with noncirrhotic MASLD and chronic hepatitis C also develop HCC, although not at high enough rates to justify screening based on current standards. These individuals, however, represent a substantial proportion of new HCC cases given rising MASLD rates and the endemic nature of hepatitis C in certain regions. Risk-stratifying these populations may reveal subsets that are higher risk and warrant screening. Several imaging advances, including contrast-enhanced ultrasound and abbreviated MRI protocols, may improve detection compared with the current approach. Evaluation of risk stratification and validation of these new imaging methods via clinical trials would likely lead to adjusting screening guidelines. This narrative review provides a diagnostic and interventional radiology-focused summary of the HCC screening guidelines and their recent evolution and highlights emerging imaging methods as potential screening tools of the future.</div></div>","PeriodicalId":49044,"journal":{"name":"Journal of the American College of Radiology","volume":"22 3","pages":"Pages 260-268"},"PeriodicalIF":4.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143529543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Using Incidental Radiologic Findings of Hepatic Steatosis to Improve the Diagnosis of Metabolic Dysfunction-Associated Steatotic Liver Disease

IF 4 3区医学

Journal of the American College of Radiology Pub Date : 2025-03-01 DOI: 10.1016/j.jacr.2024.12.014

Emily Schonfeld MD , Andrea Siobhan Kierans MD , Rena Fox MD , Danielle Brandman MD, MAS

{"title":"Using Incidental Radiologic Findings of Hepatic Steatosis to Improve the Diagnosis of Metabolic Dysfunction-Associated Steatotic Liver Disease","authors":"Emily Schonfeld MD , Andrea Siobhan Kierans MD , Rena Fox MD , Danielle Brandman MD, MAS","doi":"10.1016/j.jacr.2024.12.014","DOIUrl":"10.1016/j.jacr.2024.12.014","url":null,"abstract":"<div><div>Metabolic dysfunction-associated steatotic liver disease (MASLD) is a common cause of liver disease worldwide. In patients with MASLD, liver fibrosis stage is the most significant predictor of mortality; therefore, early identification of patients at the greatest risk of advanced fibrosis is essential. Noninvasive tests predict advanced fibrosis and are recommended for use in primary care settings to determine which patients would benefit most from specialty care. The adoption of these tools is not widespread, and several studies have reported underrecognition of cirrhosis in patients with MASLD and diabetes. The finding of hepatic steatosis on imaging performed for evaluation of nonliver conditions may present an avenue for opportunistic screening to identify more patients with MASLD. This article will review recommendations for when hepatic steatosis is found on imaging and noninvasive tests that can be used to help predict fibrosis staging. This is a significant area of research because a new treatment for MASLD has been approved, and other treatments may follow.</div></div>","PeriodicalId":49044,"journal":{"name":"Journal of the American College of Radiology","volume":"22 3","pages":"Pages 358-365"},"PeriodicalIF":4.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143529370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Realizing the Potential for Opportunistic Early Detection of Abnormalities on Medical Imaging Using Artificial Intelligence 利用人工智能实现医学影像异常早期机会性检测的潜力。

IF 4 3区医学

Journal of the American College of Radiology Pub Date : 2025-02-01 DOI: 10.1016/j.jacr.2024.09.003

Monica M. Matsumoto MD , Christoph I. Lee MD, MS, MBA

引用次数: 0

Patient-Friendly Summary of the ACR Appropriateness Criteria®: Clinically Suspected Adnexal Mass, No Acute Symptoms: 2024 Update 便于患者理解的 ACR 适宜性标准®摘要：临床疑似附件包块，无急性症状：2024 年更新。

IF 4 3区医学

Journal of the American College of Radiology Pub Date : 2025-02-01 DOI: 10.1016/j.jacr.2024.09.016

Christian P. Haskett PhD, AEMT , Alexander Lam MD

引用次数: 0

Current Status and Legislative Trends in Diversity, Equity, Inclusion in US Radiology 美国放射学的 "多样性、公平性和包容性 (DEI)"：现状与立法趋势》。

IF 4 3区医学

Journal of the American College of Radiology Pub Date : 2025-02-01 DOI: 10.1016/j.jacr.2024.07.028

Florence X. Doo MD, MA , Jordan D. Perchik MD , Nicole M. Hindman MD , Judy Yee MD , Efren J. Flores MD , Marques L. Bradshaw MD, MSCR , Elizabeth G. McFarland MD

引用次数: 0

Patient-Friendly Summary of the ACR Appropriateness Criteria®: Endometriosis 便于患者理解的 ACR 适宜性标准®摘要：子宫内膜异位症。

IF 4 3区医学

Journal of the American College of Radiology Pub Date : 2025-02-01 DOI: 10.1016/j.jacr.2024.09.015

Elizabeth M. McGuire , Sherry S. Wang MBBS

引用次数: 0

Patient-Friendly Summary of the ACR Appropriateness Criteria®: Lower Extremity Chronic Venous Disease ACR 适宜性标准®患者友好摘要：下肢慢性静脉疾病。

IF 4 3区医学

Journal of the American College of Radiology Pub Date : 2025-02-01 DOI: 10.1016/j.jacr.2024.09.014

Naomi Hoffer MA, MCHES , Lynne M. Koweek MD

引用次数: 0

Institutional Review of Usage and Referral Pattern of Radiologic Voiding Examinations (Contrast-Enhanced Voiding Urosonography and Voiding Cystourethrogram) 对放射学排尿检查（ceVUS 和 VCUG）的使用和转诊模式进行机构审查。

IF 4 3区医学

Journal of the American College of Radiology Pub Date : 2025-02-01 DOI: 10.1016/j.jacr.2024.09.008

Tatiana Morales-Tisnés MD , Mohamed M. Elsingergy MD , Travis Bevington MD , Dawud Hamdan BS , Maretta M. Smith BS , Stephanie Cajigas-Loyola MD , Hansel J. Otero MD , Dana A. Weiss MD , Susan J. Back MD

引用次数: 0

A Scoping Review of Risk Presentation in Patient Decision Aids: Communicating Risk in Imaging 在成像中传达风险：患者决策辅助工具中的风险表述范围综述》（A Scoping Review of Risk Presentation in Patient Decision Aids）。

IF 4 3区医学

Journal of the American College of Radiology Pub Date : 2025-02-01 DOI: 10.1016/j.jacr.2024.05.014

Trey A. Baird BS , Melissa Previtera MLIS , Samuel Brady PhD , Davene R. Wright PhD , Andrew T. Trout MD , Shireen E. Hayatghaibi PhD

{"title":"A Scoping Review of Risk Presentation in Patient Decision Aids: Communicating Risk in Imaging","authors":"Trey A. Baird BS , Melissa Previtera MLIS , Samuel Brady PhD , Davene R. Wright PhD , Andrew T. Trout MD , Shireen E. Hayatghaibi PhD","doi":"10.1016/j.jacr.2024.05.014","DOIUrl":"10.1016/j.jacr.2024.05.014","url":null,"abstract":"<div><h3>Purpose</h3><div>Best practices exist for communicating medical information to patients, but there is less emphasis on methods to communicate risks, especially in medical imaging. The authors conducted a scoping review of patient decision aids in medical imaging and characterized the presentation methods of imaging risks.</div></div><div><h3>Methods</h3><div>Embase, MEDLINE, CINAHL, and PsychINFO were searched to identify studies involving patient decision aids used in diagnostic imaging that communicated the risks. Study characteristics included the number and types of risks included, as well as the presentation type and how the probability of risks were communicated.</div></div><div><h3>Results</h3><div>The final study included 46 articles encompassing 27 distinct patient decision aids. Mammography was the most common imaging scenario (22 of 46), followed by lung cancer screening (18 of 46), traumatic brain injury (5 of 46), and urolithiasis (1 of 46). All patient decision aids included risks associated with imaging, but the number of risk types varied from two to nine (mean, 4 ± 2). Twelve risks were identified across the 27 decision aids, but no single study included all risks. Overall, most risks (65%) were communicated with text, and the presentation mode varied by type of risk. False-positive risks were most commonly communicated using a visual format, whereas radiation risk was most commonly communicated using text format.</div></div><div><h3>Conclusions</h3><div>There was no consistent manner of communicating risk to patients, and visual methods such as icon arrays were not consistently used. The variability of both included risks and the risk presentation modes in the patient decision aids may affect decision making, especially among patients and caregivers with lower health literacy and numeracy.</div></div>","PeriodicalId":49044,"journal":{"name":"Journal of the American College of Radiology","volume":"22 2","pages":"Pages 172-182"},"PeriodicalIF":4.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142482484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Patient-Friendly Summary of the ACR Appropriateness Criteria®: Pretreatment Staging of Urothelial Cancer: 2024 Update ACR适宜性标准®患者友好摘要：泌尿系统癌治疗前分期：2024 年更新版》。

IF 4 3区医学

Journal of the American College of Radiology Pub Date : 2025-02-01 DOI: 10.1016/j.jacr.2024.09.013

Aatiqah Aziz , Alexander Lam MD

引用次数: 0